Lumida
/CGON
⌘K
CG Oncology Inc

CG Oncology Inc

CGON
$71.85USD+3.38%+2.35 today

MARKET CAP

6.3B

P/E (TTM)

FWD P/E

DAY RANGE

$69 – $73

52W RANGE

$24
$77

AI Summary

Stalk
Buy NowMedium

CGON remains in a Stage 2 advancing corrective reset with higher highs and higher lows intact. Price has recently held above rising short-term EMAs and the 50 DMA on a shallow pullback, setting up a favorable pullback entry under a momentum + EPS strategy. Short-term timing is Bullish, as price tracks above the 9 EMA and 21 EMA with no exhaustion visible. A Buy Now execution targeting the EMA support area is appropriate. The primary risk is a deeper pullback below the EMAs and the 50 DMA, which would invalidate the bullish posture.

  • Analysts set $92.50 target, implying 53% upside.
  • Lead therapy shows 76% complete response durability.
  • Earnings yield is –1.97%, indicating weak profitability.
Full analysis →
Insider Trades4 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Mar 12, 2026BuyCGONArthur KuanChief Executive Officer66,459$3.34$6.3B-6.69%+203.81%$222.2K+18.63%Buy Now
Mar 4, 2026BuyCGONArthur KuanChief Executive Officer105,742$3.35$6.3B-6.69%+203.81%$353.8K+41.70%Buy Now
Jan 29, 2024BuyCGONVijay KasturiChief Medical Officer1,315$19.00$6.3B-6.69%+203.81%$25.0KBuy Now
Jan 29, 2024BuyCGONCorleen M. RocheCFO & Secretary2,000$19.00$6.3B-6.69%+203.81%$38.0KBuy Now